HomeCompareREUN vs MRK

REUN vs MRK: Dividend Comparison 2026

REUN yields 178.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 REUN wins by $62.86M in total portfolio value
10 years
REUN
REUN
● Live price
178.57%
Share price
$1.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.91M
Annual income
$29,936,192.20
Full REUN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — REUN vs MRK

📍 REUN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodREUNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, REUN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
REUN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REUN
Annual income on $10K today (after 15% tax)
$15,178.57/yr
After 10yr DRIP, annual income (after tax)
$25,445,763.37/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, REUN beats the other by $25,437,434.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REUN + MRK for your $10,000?

REUN: 50%MRK: 50%
100% MRK50/50100% REUN
Portfolio after 10yr
$31.49M
Annual income
$14,972,995.17/yr
Blended yield
47.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

REUN
No analyst data
Altman Z
-4.6
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REUN buys
0
MRK buys
0
No recent congressional trades found for REUN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricREUNMRK
Forward yield178.57%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$62.91M$56.8K
Annual income after 10y$29,936,192.20$9,798.13
Total dividends collected$58.90M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: REUN vs MRK ($10,000, DRIP)

YearREUN PortfolioREUN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$28,557$17,857.14$11,206$366.19+$17.4KREUN
2$78,215$47,658.78$12,650$502.35+$65.6KREUN
3$205,683$121,992.76$14,407$694.19+$191.3KREUN
4$519,899$299,818.53$16,585$967.82+$503.3KREUN
5$1,264,557$708,265.17$19,342$1,363.89+$1.25MREUN
6$2,963,097$1,610,021.03$22,913$1,947.19+$2.94MREUN
7$6,696,294$3,525,779.94$27,662$2,823.89+$6.67MREUN
8$14,611,669$7,446,634.50$34,159$4,173.35+$14.58MREUN
9$30,820,422$15,185,936.42$43,337$6,308.80+$30.78MREUN
10$62,914,044$29,936,192.20$56,776$9,798.13+$62.86MREUN

REUN vs MRK: Complete Analysis 2026

REUNStock

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Full REUN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this REUN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REUN vs SCHDREUN vs JEPIREUN vs OREUN vs KOREUN vs MAINREUN vs JNJREUN vs ABBVREUN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.